This invention relates to the field of mammalian therapy by means of ionizing radiation or laser energy applied to tumors or other imperfections in skin or near-skin tissues, or in or near other exposed anatomical surfaces.
A variety of skin or near skin medical conditions are today treated by application of x-ray, laser, or electron radiation, often after surgery to excise a tumor or other defect. Generally, the radiation treatment apparatus used for these purposes is large, expensive and unwieldy. As such, it is often unavailable in small clinic situations. Furthermore, the radiation dosage level is often imprecise in that the energy ranges available to the therapist are too great for the desired treatment, necessitating that the tumor be covered with radiation absorbing material such that the radiation passing through the absorber is more appropriate for the desired treatment. Because of the high-energy radiation levels from the machine, the patient must be extensively shielded except for the area of the tumor.
Further imprecision of current methods derives from the fact that available radiation machines have fixed output patterns which must be extensively collimated by magnetic fields and secondary shielding, often prepared specifically to treat the individual patient's tumor. Although machine output may be adjusted in a gross sense, the radiation distribution within the area of the collimated beam which is allowed to pass through the mask to treat the tumor is uncontrolled. The therapist must therefore compromise his or her treatment plan to accommodate an average energy level when it would be preferable from a therapeutic viewpoint to tailor the treatment energy levels for specific sub-regions of the tumor area.
In use, the machine is positioned over the patient; more specifically, the collimated beam passing through the secondary shielding is directed at the subject tumor site. The patient must not move once alignment is determined, otherwise the treatment is not delivered to the desired area. When all are ready, the therapist leaves the room, and treatment progresses. This situation can be intimidating or claustrophobic for the patient.
Present methods of laser therapy on surfaces is often by direct application CO2 laser energy, or by injection of agents which are attracted to and linger in abnormal tissue cells. When activated by laser, these agents are activated, destroying the abnormal tissue (e.g. Photofrin®, Axcan Pharma United States, Birmingham, Ala.). With present methods of laser therapy, the therapist must often rely on visual feedback to determine the region of treatment, and the extent or intensity of treatment within that region. Although the therapist may know quantitatively the energy required to achieve the desired therapeutic effect, the visual clues available may not accurately reflect the extent of treatment in a useful way. Hence there may remain uncertainty as to the adequacy of treatment. This in turn can lead to untreated areas within the region of interest, over-treatment, or return treatments after the effects of initial treatment become apparent.
There is therefore need for apparatus and methods for accurately and conveniently treating tumors and imperfections in surface or near-surfade tissues. It is an object of this invention to provide methods for identifying the region to be treated on the patient, planning the therapy, or radiation dose, quantitatively to be administered within that region, taking into account the known characteristics of the energy source to be utilized, and executing the therapy conveniently, and in a timely manner. Additionally, it is an object of this invention to provide a record of the therapy delivered, and verifying it was to plan. Specifically, this invention is directed to the use of small ionizing radiation sources, facilitating such radiation therapy in small clinical settings.
The preferred method of this invention includes mapping the region of therapeutic interest by a computer equipped with imaging apparatus and displaying the region on a monitor. Imaging apparatus of this sort are well known; for example, digital video camera systems are useful. Preferably, the imaging apparatus is stereoscopic or includes known methods of triangulation, for example by laser (LMI Technologies, Inc., Delta, British Columbia, Canada), such that the range from the energy source to the surface areas within the treatment region can be deduced. This is especially important for determining the dose delivered where the treatment region is not substantially flat, or is extensive. To accomplish this mapping, the therapist may outline the region physically on the patient, for example by a marker pen, such that the region may be automatically scanned, or by direct acquisition by the computer based on imaging the tumor or other defect by its characteristics, and outlining of the region of interest by the therapist on the monitor, for example by known mouse or tablet and pen-based methods (Wacom Technologies Corp., Vancouver, Wash.).
With this image and the treatment region boundaries defined, the therapist can plan his course of treatment, for example again by tablet and pen-based input for the local dose needed. Computer smoothing of discrete input data over the region can be applied as desired. Dose delivered may be deduced from energy source input parameters, for example voltage and current in the case of an x-ray source, and proximity sensors (for example laser triangulation) to determine range from energy source to the treatment surface, to calculate the energy flux incident on the surface being treated, and cumulative dwell over each location. When the desired treatment level has been reached for a given location, or when the beam passes outside the treatment region boundary, the beam of energy incident on that area may be interrupted.
Verification can be in real time, with radiation sensors adjacent to the target tissue. These may be in the periphery of the radiation beam, or directly on the tissue region, and their feedback can be used to control the delivery of energy to the region or to subregions of the region.
The energy source may be automatically or manually scanned, aiming the source at the treatment area in sequential steps or continuously, methodically or randomly, in order to deliver the planned therapy. Continuous imaging of the area around the incident radiation and comparison with the original mapping accurately establishes the location of incident radiation within the treatment area. Computation of the cumulative dose by location (or real time incident radiation measurement) is used both to display the progress of treatment and to control radiation delivered. Apparatus capable of real-time image recognition of this sort is well known, and not unlike that for missile location determination, although obviously at much shorter range (National Instruments, Austin, Tex.). Recording the delivered dose locally provides verification that the planned dose was achieved. As an adjunct or alternative to computer generated verification of dose delivered, and as noted above, in-beam dosimeters can be used but can present the disadvantage of creating a shadow in the incident radiation unless placed in peripheral areas of the beam. Surface mounted dosimeters could be used in place of, or in conjunction with the methods described, and local shadowing can be overcome by embedding the dosimeters in openings in an attenuating shield having the same shielding density as the dosimeters.
Although this invention is largely described with respect to therapeutic application of ionizing radiation, the same planning and treatment control, turning the energy source on and off as planned therapy is achieved, is equally applicable to laser therapy. It is particularly useful where any surface effects from treatment visually obscure the extent of treatment and therefore limit the therapist's ability to optimally conclude treatment.
a shows a shutter mechanism capable of interrupting the energy beam in the closed position.
b shows the shutter mechanism in the open position.
The preferred method of use of this apparatus comprises first imaging the patient at least once using a relatively wide exposure angle at a known distance from the treatment surface such that the treatment region, and somewhat beyond, is included in good detail and displayed on the monitor 102. Detail is necessary for both location recognition and ranging as described below. If the region 104 to be treated is sufficiently non-planar, it may be desirable to take more than one wide angle image. Next the treatment region 104 is identified for acquisition by the CPU 101. If the treatment region was defined on the patient physically, this region is displayed on the monitor 102 as 104. If not identified physically on the patient, the treatment region 104 may be indicated on the monitor 102 display using, for example, tablet and pen-based input means. With the treatment region defined, the operator may then proceed to assign treatment parameters (dose) within that region, again by tablet and pen-based means. Other types of input methods might also be used.
In a preferred method of this invention, the radiation energy source utilized is disclosed in U.S. Pat. No. 6,319,188, “Vascular X-Ray Probe”, adapted as to power and for forward or distal projecting radiation. The specification of U.S. Pat. No. 6,319,188 is incorporated herein by reference in its entirety. The energy source 300 may be a hand held instrument, comprised for example of a central energy source 300 and an adjacent or coaxial camera 400 near or surrounding the source. The energy source 300 is in communication with the power source 200 to receive the voltage, current and, in one embodiment, laser energy necessary to deliver controlled radiation energy to each sub-region within the treatment region 104 in accordance with the treatment plan. The adjacent or coaxial camera 400 is in communication with the CPU 101 in order to provide the wide angle image of the patient used in preparation of the treatment plan noted above, and to continuously match shorter range images with the wide angle view used to create the treatment plan within the treatment region 104. By identifying and matching landmarks (natural or artificial) on the wide angle and treatment images, the location of the incident radiation can be determined. Further, by comparing the scale between imaged landmarks proportionally during treatment to the scale between the same landmarks on the wide angle image most normal to the treatment surface, range from the energy source 300 to the treatment surface may be deduced and serve as a real-time basis for voltage and current adjustments to the energy source, modulating radiation output to provide incident radiation as planned. In this manner, the cumulative incident radiation and dwell can be matched to the total treatment planned for that location. Alternatively, other proximity determination methods could be used, such as laser triangulation. In an intra-operative, sterile context, independently guided laser spots could be used to provide reference landmarks.
If desired, calibration or verification of system radiation output before and after treatment can be provided using known flat-panel x-ray detector, ion chamber array, or film methods. This would provide real verification that the energy source 300 is in good order before starting treatment, and verification that treatment was to plan.
When the therapist is ready to administer therapy to the patient, the energy source 300 is enabled at the controller 100 such that radiation can be delivered when positioned over the treatment area 104 in accordance with the treatment plan, and when the energy source 300 is activated. Activation can advantageously be by push button on the energy source 300 and camera 400 assembly, or alternately by foot pedal, for example.
As the energy source 300 is scanned during the treatment phase, whether by manual or automated protocol, the controller 100 computes the incident level of treatment by specific sub-region using range and energy source output to integrate the cumulative treatment over time until the cumulative dose reaches the treatment plan level for that sub-region, at which point the energy beam is blocked. This may be accomplished by an operable shutter 500 as depicted in
As noted above, when the prescribed level of therapy has been achieved, or when the beam leaves the defined treatment region, the shutter 403 will close or the beam will switch off, and a signal can be used to advise the therapist to move to an area still in need of further treatment. Signaling might be, for example, by coloring the area on the monitor within the treatment region which has received adequate treatment, perhaps in an analog manner such that the darker the color, the more nearly complete the treatment in that area. Optionally, after complete treatment of a sub-region, the color could shift to a different color altogether. The operator can also be notified the beam is off by an audible signal. Should the therapist later again direct the beam to an area already adequately treated, or leave the treatment region, the shutter will again close (or radiation will be switched off) in order to prevent over-treatment. Where manual scanning is used, audible signals can be useful in guiding the therapist within a proper distance range from the treatment surface. For example, a low pitched tone or fast beeping signal could indicate the energy source 300 is too close to the surface, whereas a high tone or slow beeping would indicate too great a range. Typical treatment ranges might be from 0.1 to 10 cm between the energy source 300 and treatment surface. Tones can also be used to indicate percentage completion of planned treatment by specific region. A record of a fully dark colored, or different colored treatment region on the monitor can serve as verification that the planned treatment has been delivered. In the case of automated scanning, signaling may not be necessary. However, a record of the darkened or differently colored image on the monitor can still be useful as verification of treatment to plan. Alternatively, as treatment progresses, the fully treated areas can be eliminated from the treatment region on the monitor, leaving only those areas still in need of further treatment.
A further hand-held embodiment includes a stage over the treatment region on which a plate, with the energy source mounted normal to the plate, slides when moved by hand. Such apparatus can both decrease operator fatigue and assure the range between the energy source and treatment region and the incident angle are known.
Although this method is described in relation to low-energy x-ray sources, it may in principle be applied to other energy sources, non-x-ray, or to higher power sources. This method eliminates potential treatment error due to patient movement because, by actively and continuously acquiring camera images of the treatment region, it delivers therapy to the treatment region where the patient is in real time, rather than to where the patient was during creation of the treatment plan, or at some subsequent point. With this method, therapy to a predetermined plan can be accomplished and verified, and ensuring that over-treatment is eliminated, thus assuring a safe therapeutic effect.
The system and method of this invention is less elaborate and more space efficient than an automated system, making it more attractive in a small clinic setting. It is less costly, is easier to use for the therapist and less intimidating to the patient.
The delivery system needs to deliver the treatment to the region without under- or over-treating any part of the region and minimizing the dose delivered outside the region (801x). Radiation is delivered to the treatment region and is monitored by the radiation detector 702. The location of the radiation treatment system (i.e. the source 300) preferably is monitored by a camera 600. Combining knowledge of the radiation delivered by the radiation source using detector 702, the location of the treatment system and how long the radiation system dwells at each location within the treatment region allows the controller to display the amount of treatment delivered to each of the areas within the region. The information can then be displayed on the monitor to show where the region has been under-, over- and correctly treated. Using a radiation detector that is at the fringe of the radiation minimizes the detector shadowing of tissue to be treated. This approach depends on measuring the radiation beam distribution and knowing the distance of the detector from the treatment surface.
It should be understood that other means of determination of the location of the radiation treatment system 310 can be used. For example, the location can be known through mechanical indexing of the position of the radiation source, in the event such an automatic indexing system is used, rather than hand-controlled movement.
All of the above procedures and equipment can be used in connection with image re-acquisition software, as mentioned above, whereby a camera, in a larger field than the treatment area, constantly monitors either the treatment area or the larger portion of the patient around the treatment area and, in the event of movement of the patient, re-acquires the image and corrects the position of the radiation source accordingly.
It should be understand that the radiation, although often described above in terms of an electronic x-ray source, can alternatively comprise other ionizing radiation or even laser radiation. Other ionizing radiation can comprise, for example, electronic beam radiation, alpha particles, beta particles or protons in the case of x-ray radiation, preferably a miniature, controllable electronic x-ray source is used, at a voltage in the range of about 10 kV to 70 kV, more preferably about 10 kV to 30 kV.
The above described preferred embodiments are intended to illustrate the principles of the invention, but not to limit its scope. Other embodiments and variations to these preferred embodiments will be apparent to those skilled in the art and may be made without departing from the spirit and scope of the invention as defined in the following claims.
This application claims benefit of provisional application No. 60/472,118, filed Dec. 2, 2005.
Number | Date | Country | |
---|---|---|---|
60742118 | Dec 2005 | US |